Clinical Trials Grant (osteosarcoma)

The Clinical Trials Grant from the Osteosarcoma Institute supports researchers worldwide planning to conduct clinical trials in osteosarcoma. The proposed trial may be conducted at a single institution, a clinical trial consortium, or through an existing clinical trial infrastructure. The results of the proposed trial should be expected within 3 years. Applicants may apply for up to 800,000 USD. Letters of intent are due on November 15, 2021. Invited full applications are due on April 14, 2022.


Letter of inquiry (LOI) closing date: 

November 15, 2021

Full-application closing date: 

April 14, 2022

Grant type:

Research Grant

Grant duration:

3 years

Grant amount:

800,000 USD

Recipient qualification:

Any doctoral degree

Recipient citizenship:


Host location: